Market LIVE
Published markets; coverage varies by country
Product profile · United States

ZELSUVMI

 ·  Patent Litigation & Settlement History ↓

IngredientBERDAZIMER SODIUM
Application typeNDA
Application217424
Product001
Dosage formGEL
RouteTOPICAL
StrengthEQ 10.3% BASE
Approval date2024-01-05
Marketing statusPrescription
Status event—
ApplicantLNHC
Product source

Current GenericRadar decision

Year2029
SelectionDEEP_REVIEW
ReviewFINAL
Anchor typeREGULATORY_EXCLUSIVITY
Anchor date2029-01-05
Patent anchor2026-05-30
Exclusivity anchor2029-01-05
Protection date2035-07-10
First Final ANDA—
Status event—

GNR judgment: DEEP_REVIEW. Reference year: 2029. Anchor type: REGULATORY_EXCLUSIVITY. Patent anchor: 2026-05-30. Exclusivity anchor: 2029-01-05. Anchor date: 2029-01-05. Patent tail: yes. Exclusivity tail: no. Review status: FINAL. Historical detailed rationale is retained in the evidence snapshot; this is a structured English summary, not a literal translation.

Patent estate

PatentEffective dateOfficial listingTRUE_DSDS gradeClaim classification / basisPTEPEDFamily
82829672026-05-30DS —NNPROCESS
English description not available.
———
82829672026-05-30ORANGE_BOOK —NNPROCESS
English description not available.
———
89566582026-05-30DS —YNTRUE_DS
English description not available.
———
89566582026-05-30ORANGE_BOOK —YNTRUE_DS
English description not available.
———
103765382030-08-20DP —NNDP
English description not available.
———
103765382030-08-20ORANGE_BOOK —NNDP
English description not available.
———
97375612030-08-20U U-3802NNU
English description not available.
———
97375612030-08-20ORANGE_BOOK U-3802NNU
English description not available.
———
95267382031-09-03DP —NNDP
English description not available.
———
95267382031-09-03ORANGE_BOOK —NNDP
English description not available.
———
102653342032-07-03DP —NNDP
English description not available.
———
102653342032-07-03ORANGE_BOOK —NNDP
English description not available.
———
92894422032-07-03DP/U U-3803NNDP
English description not available.
———
92894422032-07-03ORANGE_BOOK U-3803NNDP
English description not available.
———
98552112034-02-27DP/U U-3801NNDP
English description not available.
———
98552112034-02-27DP/U U-3800NNDP
English description not available.
———
98552112034-02-27ORANGE_BOOK U-3800;U-3801NNDP
English description not available.
———
112850982034-02-28DP —NNDP
English description not available.
———
112850982034-02-28ORANGE_BOOK —NNDP
English description not available.
———
102585642034-11-22U U-3797NNU
English description not available.
———
102585642034-11-22U U-3799NNU
English description not available.
———
102585642034-11-22U U-3798NNU
English description not available.
———
102585642034-11-22ORANGE_BOOK U-3797;U-3798;U-3799NNU
English description not available.
———
103220812035-07-10U U-3794NNU
English description not available.
———
103220812035-07-10U U-3796NNU
English description not available.
———
103220812035-07-10U U-3793NNU
English description not available.
———
103220812035-07-10U U-3795NNU
English description not available.
———
103220812035-07-10ORANGE_BOOK U-3793;U-3794;U-3795;U-3796NNU
English description not available.
———
107368392035-07-10U U-3791NNU
English description not available.
———
107368392035-07-10U U-3790NNU
English description not available.
———
107368392035-07-10U U-3792NNU
English description not available.
———
107368392035-07-10ORANGE_BOOK U-3790;U-3791;U-3792NNU
English description not available.
———
110400062035-07-10DP/U U-3789NNDP
English description not available.
———
110400062035-07-10ORANGE_BOOK U-3789NNDP
English description not available.
———
117238582035-07-10DP/U U-3788NNDP
English description not available.
———
117238582035-07-10ORANGE_BOOK U-3788NNDP
English description not available.
———

Regulatory exclusivity

CodeStart dateEnd dateScopeEntire productAll indicationsFull coverage dateCombinationSource
NCE2024-01-052029-01-05English description not available.YY2029-01-05—Source
NCE2024-01-052029-01-05English description not available.YY2029-01-05
NCE
Full coverage date: 2029-01-05
Source

2026-10-10 · CURRENT_SOURCE_RECORDS_FOUND · Historical coverage: NOT_COMPLETE

Generic approval evidence

Application / productEventFinal dateTentative dateApplicantAuthorized genericExact mappingSource
No generic approval facts are linked to this product.

Market Entry Information

API filings, authorized generics and linked regulatory milestones.

API Master Files & Certifications 0 records

Ingredient-level registrations from linked public manufacturer portfolios. A filing does not establish supply to this finished product. DMFs are not FDA approvals.

APIHolder / manufacturerHolder countryFiling typeNumberStatusFiled dateAvailable for referenceSourceLast verified
No master-file or certification records are linked through public manufacturer portfolios.

Authorized Generics 0 records

Authorized generics are shown separately from independent ANDA approvals.

Application / productApplicantEvent / status First marketed Product mappingSourceLast verified
No authorized-generic records are linked to this product.

Tentative ANDA Approvals 0 records

Tentative approval is not final approval. Historical tentative approvals remain visible after a linked final approval.

Application / productApplicantEvent / status Tentative date Follow-up final approvalProduct mappingSourceLast verified
No tentative-approval records are linked to this product.

Paragraph IV Challenges 0 records

Paragraph IV challenges below are sourced from legal records separately from FDA approvals. An ANDA filing, lawsuit or settlement does not establish final approval or commercial launch.

Application / productApplicantEvent / status Certification event date Product mappingSourceLast verified
No structured Paragraph IV certification events are linked in the available approval evidence.

Final ANDA Approvals 0 records

Approval dates do not establish commercial launch. Product mapping is shown for each linked record.

Application / productApplicantEvent / status Final approval date Product mappingSourceLast verified
No final-approval records are linked to this product.
Decision evidence (16)
TypeDateRoleBasisSource
PATENT2026-05-30HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2026-05-30CANONICAL_ANCHOREnglish description not available.Source
PATENT2030-08-20FTO_TAILEnglish description not available.Source
PATENT2030-08-20FTO_TAILEnglish description not available.Source
PATENT2031-09-03FTO_TAILEnglish description not available.Source
PATENT2032-07-03FTO_TAILEnglish description not available.Source
PATENT2032-07-03FTO_TAILEnglish description not available.Source
PATENT2034-02-27FTO_TAILEnglish description not available.Source
PATENT2034-02-28FTO_TAILEnglish description not available.Source
PATENT2034-11-22FTO_TAILEnglish description not available.Source
PATENT2035-07-10FTO_TAILEnglish description not available.Source
PATENT2035-07-10FTO_TAILEnglish description not available.Source
PATENT2035-07-10FTO_TAILEnglish description not available.Source
PATENT2035-07-10FTO_TAILEnglish description not available.Source
REGULATORY_EXCLUSIVITY—CANONICAL_ANCHOREnglish description not available.Source
REGULATORY_STATUS2029-01-05CANONICAL_DECISIONEnglish description not available.Source
Independent legal-event information

Litigation & Settlement History

Settlement launch rights generally apply only to the named parties and product scope. These records do not change GenericRadar patent/exclusivity anchors or current decisions.

No litigation or settlement record currently linked to this product.